Peripheral neuropathy linked to heart risk

THE study in 13,000 primary care patients without cardiovascular disease at baseline, showed that survival after 30 months of follow-up was 89.4% among patients with peripheral neuropathy, compared with 94.4% among patients without, after adjusting for HbA1c.

Including peripheral neuropathy in a model based on standard cardiovascular risk, improved discrimination for risk prediction and reclassified 7% of patients into higher or lower risk categories.

“There may be an opportunity to use data on peripheral neuropathy for identifying